Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Heidrick & Struggles International, Inc. (HSII) Really Struggles: Korn/Ferry International (KFY), Insperity Inc (NSP)

I like buying into businesses with variable cost structures. These kinds of companies have somewhat of a protected downside; when things go south, costs can be removed such that the firm may remain profitable, subject to a period of adjustment. Executive search firm Heidrick & Struggles International, Inc. (NASDAQ:HSII), which saw its shares fall 20% on Tuesday, appears to have such a model.

Heidrick trades for under $250 million despite a net cash position of almost $120 million and cash flow from operations of over $100 million over the last four years. As you might expect, demand for its services (recruitment of C-level personnel) rises and falls sharply with the business cycle, which can cause heavy volatility in the stock price.

Heidrick & Struggles International, Inc. (NASDAQ:HSII)This is exactly the kind of situation in which a value investor might be interested: a volatile stock for a company whose downside is protected in the form of a flexible cost structure. The flexible cost structure is the result of fact that most of the expenses in this firm are made up of consultant labour costs. If your revenue no longer justifies carrying these consultants, they can be let go. Such is not the case when your labour costs come in the form of unions or pensions, for example, or when a large part of your costs are otherwise fixed (e.g. in the case of leases or plant machinery).

But while Heidrick & Struggles International, Inc. (NASDAQ:HSII) may seem like an ideal stock in theory, in practice it’s not exactly working out that way. The company has seen its per-share book value (adjusted for dividends) grow by just 3.8% per year over the last 10 years.

My theory for this disconnect is that the firm is run for the benefit of its employees, rather than its shareholders. The value created due to the beneficial characteristics of this industry appears to accrue to management/consultants.

The evidence is overwhelming. The company has managed to lose money in five of the last 11 years, despite the fact that annual revenue per consultant is over $1 million. This suggests that shareholders bear the brunt of the volatile nature of this business. The share count was flat over this period, despite some heavy buybacks, as employees have benefited handsomely from options and restricted shares.

Finally, despite the poor returns on book value, the company is a serial acquirer of other businesses. Just last quarter, the company dropped six times EBITDA to buy another consulting firm, spending almost one quarter of its current market cap on the transaction!

While Heidrick & Struggles International, Inc. (NASDAQ:HSII) is undoubtedly cheap, it may not be cheap enough for a value investor to put up with such shareholder-unfriendly actions. Neither competitors Korn/Ferry International (NYSE:KFY) nor Insperity Inc (NYSE:NSP) seem to suffer from the same problems. They both show strong returns on capital and healthy margins, suggesting that shareholders are allowed to share in the bounty. Unfortunately, one currently has to pay a premium for these superior companies.

The article Heidrick Really Struggles originally appeared on and is written by Sajid Karsan.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!